# A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan

> **NCT00421811** · PHASE1,PHASE2 · COMPLETED · sponsor: **Adherex Technologies, Inc.** · enrollment: 56 (estimated)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** ADH-1
- **DRUG:** melphalan

## Key facts

- **NCT ID:** NCT00421811
- **Lead sponsor:** Adherex Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2010-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421811, "A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00421811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*